Walking of antitumor bifunctional trinuclear PtII complex on double-helical DNA

Nucleic Acids Research

Volumn 39, Issue 2, 2011, Pages 720-728

  Malina, Jaroslav ^a   Kasparkova, Jana ^b   Farrell, Nicholas P ^c   Brabec, Viktor ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA; PLATINUM COMPLEX; TRIPLATIN TETRANITRATE;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DNA ADDUCT; DNA CONFORMATION; DNA CROSS LINKING; ISOMERIZATION; PRIORITY JOURNAL; THERMODYNAMICS;

ANTINEOPLASTIC AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; CROSS-LINKING REAGENTS; DNA; DNA ADDUCTS; ORGANOPLATINUM COMPOUNDS; THERMODYNAMICS;

EID: 79551483886     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkq803     Document Type: Article

References (31)

1. Hurley, L.H. (2002) DNA and its associated processes as targets for cancer therapy. Nature Rev. Cancer, 2, 188-200.
2. Cusumano, M., DiPietro, M.L., Giannetto, A., Messina, M.A. and Romano, F. (2001) Catalysis and inhibition of ligand substitution in palladium(II) square-planar complexes: Effects of DNA. J. Am. Chem. Soc., 123, 1914-1919.
3. Davies, M.S., Berners-Price, S.J., Cox, J.W. and Farrell, N. (2003) The nature of the DNA template (single-versus double-stranded) affects the rate of aquation of a dinuclear Pt anticancer drug. Chem. Commun., 122-123.
4. Comess, K.M., Costello, C.E. and Lippard, S.J. (1990) Identification and characterization of a novel linkage isomerization in the reaction of trans-diamminedichloroplatinum(II) with 50-d (TCTA CGCGTTCT). Biochemistry, 29, 2102-2110.
5. Perez, C., Leng, M. and Malinge, J.M. (1997) Rearrangement of interstrand cross-links into intrastrand cross-links in cis-diamminedichloroplatinum(II)- modified DNA. Nucleic Acids Res., 25, 896-903.
6. Giraud-Panis, M.-J. and Leng, M. (2000) Transplatin-modified oligonucleotides as modulators of gene expression. Pharmacol. Therapeutics, 85, 175-181.
7. Chvalova, K., Brabec, V. and Kasparkova, J. (2007) Mechanism of the formation of DNA-protein cross-links by antitumor cisplatin. Nucleic Acids Res., 35, 1812-1821.
8. Kane, S.A. and Lippard, S.J. (1996) Photoreactivity of platinum(II) in cisplatin-modified DNA affords specific cross-links to HMG domain proteins. Biochemistry, 35, 2180-2188.
9. Farrell, N. (2004) Polynuclear platinum drugs. In Sigel, A. and Sigel, H. (eds), Metal Ions in Biological Systems, Vol. 42. Marcel Dekker Inc., New York, Basel, pp. 251-296.
10. Farrell, N., Kelland, L.R., Roberts, J.D. and Van Beusichem, M. (1992) Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine-L1210 and human tumor panels and studies on their mechanism of action. Cancer Res., 52, 5065-5072.
11. Jamieson, E.R. and Lippard, S.J. (1999) Structure, recognition, and processing of cisplatin-DNA adducts. Chem. Rev., 99, 2467-2498.
12. Wang, D. and Lippard, S.J. (2005) Cellular processing of platinum anticancer drugs. Nature Rev. Drug Discov., 4, 307-320.
13. Davies, M.S., Thomas, D.S., Hegmans, A., Berners-Price, S.J. and Farrell, N. (2002) Kinetic and equilibria studies of the aquation of the trinuclear platinum phase II anticancer agent [{trans-PtCl(NH3)2}2{m-trans-Pt(NH3) 2(NH2(CH2)6NH2)2}]4+ (BBR3464). Inorg. Chem., 41, 1101-1109.
14. McGregor, T.D., Hegmans, A., Kasparkova, J., Neplechova, K., Novakova, O., Penazova, H., Vrana, O., Brabec, V. and Farrell, N. (2002) A comparison of DNA binding profiles of dinuclear platinum compounds with polyamine linkers and the trinuclear platinum phase II clinical agent BBR3464. J. Biol. Inorg. Chem., 7, 397-404.
15. Brabec, V., Kasparkova, J., Vrana, O., Novakova, O., Cox, J.W., Qu, Y. and Farrell, N. (1999) DNA modifications by a novel bifunctional trinuclear platinum Phase I anticancer agent. Biochemistry, 38, 6781-6790.
16. Hegmans, A., Berners-Price, S.J., Davies, M.S., Thomas, D., Humphreys, A. and Farrell, N. (2004) Long range 1, 4 and 1, 6-interstrand cross-links formed by a trinuclear platinum complex. Minor groove pre-association affects kinetics and mechanism of cross-link formation as well as adduct structure. J. Am. Chem. Soc., 126, 2166-2180.
17. Kasparkova, J., Zehnulova, J., Farrell, N. and Brabec, V. (2002) DNA interstrand cross-links of the novel antitumor trinuclear platinum complex BBR3464. Conformation, recognition by high mobility group domain proteins, and nucleotide excision repair. J. Biol. Chem., 277, 48076-48086.
18. Zehnulova, J., Kasparkova, J., Farrell, N. and Brabec, V. (2001) Conformation, recognition by high mobility group domain proteins, and nucleotide excision repair of DNA intrastrand cross-links of novel antitumor trinuclear platinum complex BBR3464. J. Biol. Chem., 276, 22191-22199.
19. Ruhayel, R.A., Moniodis, J.J., Yang, X., Kasparkova, J., Brabec, V., Berners-Price, S.J. and Farrell, N.P. (2009) Factors affecting DNA-DNA interstrand cross-links in the antiparallel 30-30 sense: A comparison with the 50-50 directional isomer. Chem. Eur. J., 15, 9365-9374.
20. Cox, J.W., Berners-Price, S., Davies, M.S., Qu, Y. and Farrell, N. (2001) Kinetic analysis of the stepwise formation of a long-range DNA interstrand cross-link by a dinuclear platinum antitumor complex: Evidence for aquated intermediates and formation of both kinetically and thermodynamically controlled conformers. J. Am. Chem. Soc., 123, 1316-1326.
21. Brabec, V., Reedijk, J. and Leng, M. (1992) Sequence-dependent distortions induced in DNA by monofunctional platinum(II) binding. Biochemistry, 31, 12397-12402.
22. Kasparkova, J., Farrell, N. and Brabec, V. (2000) Sequence specificity, conformation, and recognition by HMG1 protein of major DNA interstrand cross-links of antitumor dinuclear platinum complexes. J. Biol. Chem., 275, 15789-15798.
23. Malina, J., Hofr, C., Maresca, L., Natile, G. and Brabec, V. (2000) DNA interactions of antitumor cisplatin analogs containing enantiomeric amine ligands. Biophys. J., 78, 2008-2021.
24. Hofr, C. and Brabec, V. (2001) Thermal and thermodynamic properties of duplex DNA containing site-specific interstrand cross-link of antitumor cisplatin or its clinically ineffective trans isomer. J. Biol. Chem., 276, 9655-9661.
25. Nová ková, O., Malina, J., Kas pá rková, J., Halá miková, A., Bernard, V., Intini, F., Natile, G. and Brabec, V. (2009) Energetics, conformation, and recognition of DNA duplexes modified by methylated analogues of [PtCl(dien)]+. Chem. Eur. J., 15, 6211-6221.
26. Brabec, V. and Leng, M. (1993) DNA interstrand cross-links of trans-diamminedichloroplatinum(II) are preferentially formed between guanine and complementary cytosine residues. Proc. Natl Acad. Sci. USA, 90, 5345-5349.
27. Boudvillain, M., Dalbies, R., Aussourd, C. and Leng, M. (1995) Intrastrand cross-links are not formed in the reaction between transplatin and native DNA: relation with the clinical inefficiency of transplatin. Nucleic Acids Res., 23, 2381-2388.
28. Poklar, N., Pilch, D.S., Lippard, S.J., Redding, E.A., Dunham, S.U. and Breslauer, K.J. (1996) Influence of cisplatin intrastrand crosslinking on the conformation, thermal stability, and energetics of a 20-mer DNA duplex. Proc. Natl Acad. Sci. USA, 93, 7606-7611.
29. Pilch, D.S., Dunham, S.U., Jamieson, E.R., Lippard, S.J. and Breslauer, K.J. (2000) DNA sequence context modulates the impact of a cisplatin 1, 2-d(GpG) intrastrand cross-link an the conformational and thermodynamic properties of duplex DNA. J. Mol. Biol., 296, 803-812.
30. Kasparkova, J., Mellish, K.J., Qu, Y., Brabec, V. and Farrell, N. (1996) Site-specific d(GpG) intrastrand cross-links formed by dinuclear platinum complexes. Bending and NMR studies. Biochemistry, 35, 16705-16713.
31. Marky, L.A. and Breslauer, K.J. (1987) Calculating thermodynamic data for transitions of any molecularity from equilibrium melting curves. Biopolymers, 26, 1601-1620.